Effect of ROR1-targeting small molecules on chronic lymphocytic leukemia (CLL) cells.

6557 Background: There is a great interest to develop targeting drugs for CLL, both MAbs and small molecules, to improve the outcome for the disease. ROR1, a receptor tyrosine kinase, is overexpres...